In the SURMOUNT-1 study, a phase 3 clinical trial in obese patients, randomized participants in a 1:1:1:1 ratio to tirzepatide (5, 10, 15 mg) or placebo over 72 weeks, significant weight reductions were observed at 72 weeks: 15.0% for 5 mg, 19.5% for 10 mg, 20.9% for 15 mg, compared to 3.1% for placebo [18]
Incidents related to aspiration or regurgitation of gastric contents after appropriate fasting, can be reported to the Canada Vigilance Program at or to ISMP Canada through the Individual Practitioner Reporting portal at The Canadian Medication Incident Reporting and Prevention System (CMIRPS) is a collaborative pan-Canadian program of Health Canada, the Canadian Institute for Health Information (CIHI), the Institute for Safe Medication Practices Canada (ISMP Canada) and Healthcare Excellence Canada (HEC)
I think were looking at, they are broadly effective and therapeutic for the brain
If you take insulin or sulfonylureas for diabetes, monitor your blood glucose closely when reducing calorie intake, as you may be at increased risk for hypoglycemia and require medication adjustments
Experts say this can be because of belching (and therefore not bad breath), halitosis, or ketosis
Side Effect Monitoring & Trends This tool allows users to log various side effects such as nausea, fatigue, and appetite changes
